Phase Ib trial of HLA-DQ2 peptide vaccine for coeliac disease.

Trial Profile

Phase Ib trial of HLA-DQ2 peptide vaccine for coeliac disease.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 May 2016

At a glance

  • Drugs HLA DQ2 peptide vaccine (Primary)
  • Indications Coeliac disease
  • Focus Adverse reactions
  • Sponsors ImmusanT
  • Most Recent Events

    • 04 Sep 2012 Planned study phase changed from IIa to Ib, as reported in an Immusan media release.
    • 04 Sep 2012 Status changed from planning to recruiting.
    • 16 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top